more

Griffon (GFF)

(Delayed Data from NYSE)

$68.27 USD

+0.86 (1.28%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $68.27 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.20%
2	Buy	18.04%
3	Hold	9.52%
4	Sell	5.20%
5	Strong Sell	2.60%
S&P	500	11.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5 4

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth C Momentum A VGM

Industry Rank:

Bottom 31% (175 out of 252)

Industry: Diversified Operations

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Bet on These 4 High-Flying Stocks With Increasing Cash Flows

by Moumita C. Chattopadhyay Published on March 14,2024

Cash is the key to a company's existence, development and success. It indicates a company's true financial health. Hence, MOD, GFF, HNI and BWMX, with rising cash flows, are worth buying.

Danaher (DHR) Benefits From Business Strength Amid Risks

by Zacks Equity Research Published on March 13,2024

Danaher (DHR) gains from strength in academic and life science research markets, Abcam buyout and pro-investor policies. However, softness in its Biotechnology and Diagnostics units is concerning.

multi-sector-conglomerates

Finding Great Momentum Stocks to Buy in March and Beyond

by Benjamin Rains Published on March 12,2024

The screen we explore today helps investors find stocks experiencing the strongest upward earnings revisions activity. Alongside their beefed-up EPS outlooks, the screen we dive into finds stocks that have climbed to trade near 52-week highs.

GFFPositive Net Change

construction

3M's (MMM) Board Approves Health Care Business Spin-Off

by Zacks Equity Research Published on March 11,2024

3M's (MMM) board approves the separation of its health care unit into a separate public company. The spun-off entity is set to be renamed as Solventum Corporation.

multi-sector-conglomerates

Griffon (GFF) Stock Moves -0.55%: What You Should Know

by Zacks Equity Research Published on March 08,2024

Griffon (GFF) concluded the recent trading session at $69.25, signifying a -0.55% move from its prior day's close.

GFFPositive Net Change

Griffon (GFF) Ascends But Remains Behind Market: Some Facts to Note

by Zacks Equity Research Published on March 07,2024

Griffon (GFF) concluded the recent trading session at $69.63, signifying a +0.36% move from its prior day's close.

GFFPositive Net Change

Zacks Industry Outlook Highlights Carlisle Companies, Griffon and Vector Group

by Zacks Equity Research Published on March 05,2024

Carlisle Companies, Griffon and Vector Group have been highlighted in this Industry Outlook article.

finance

Zacks.com featured highlights Griffon, HNI, ADMA Biologics and First Bank

by Zacks Equity Research Published on March 05,2024

Griffon, HNI, ADMA Biologics and First Bank have been highlighted in this Screen of The Week article.

medical

Is It Worth Investing in Griffon (GFF) Based on Wall Street's Bullish Views?

by Zacks Equity Research Published on March 04,2024

According to the average brokerage recommendation (ABR), one should invest in Griffon (GFF). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

GFFPositive Net Change

3 Stocks to Buy From the Prosperous Diversified Operations Industry

by Avisekh Bhattacharjee Published on March 04,2024

The Zacks Diversified Operations industry participants have been gaining from strength across aerospace, defense and oil and gas industries. CSL, GFF and VGR are notable stocks in the industry.

multi-sector-conglomerates

4 Stocks With Increasing Cash Flows to Enrich Your Portfolio

by Moumita C. Chattopadhyay Published on March 04,2024

Looking beyond profits to a company's cash position will be far more rewarding as this highlights its true financial health. Hence, GFF, HNI, ADMA and FRBA are worth buying.

Here's What Could Help Griffon (GFF) Maintain Its Recent Price Strength

by Zacks Equity Research Published on March 01,2024

Griffon (GFF) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

GFFPositive Net Change

Is Griffon (GFF) Stock Outpacing Its Conglomerates Peers This Year?

by Zacks Equity Research Published on February 29,2024

Here is how Griffon (GFF) and Sumitomo Corp. (SSUMY) have performed compared to their sector so far this year.

Here's Why Hold Strategy is Apt for Markel Group (MKL) Now

by Zacks Equity Research Published on February 29,2024

Markel Group (MKL) is poised to gain from rate increases, strategic buyouts, new business volume, solid capital position and favorable growth estimates.

insurance

Griffon Corporation (GFF) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research Published on February 27,2024

Griffon (GFF) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks.com featured highlights include Griffon, Centrus Energy, Tactile Systems Technology and Copa Holdings

by Zacks Equity Research Published on February 27,2024

Griffon, Centrus Energy, Tactile Systems Technology and Copa Holdings are part of the Zacks Screen of the Week article.

4 Stocks With Solid Net Profit Margin to Boost Portfolio Returns

by Anirudha Bhagat Published on February 26,2024

Pick these four top-ranked stocks ¿¿¿ Griffon (GFF), Centrus Energy (LEU), Tactile Systems Technology (TCMD) and Copa Holdings (CPA) ¿¿¿with solid net profit margins to enhance your portfolio returns.